Basic Information
UTROGESTAN CAPSULE 200mg
CAPSULE, LIQUID FILLED
Regulatory Information
SIN15475P
April 30, 2018
Prescription Only
Therapeutic
ORAL, VAGINAL
August 10, 2023
June 3, 2025
XG03DA04
Company Information
PHARMED IMPORT & EXPORT PTE LTD
PHARMED IMPORT & EXPORT PTE LTD
Active Ingredients
Strength: 200mg
Detailed Information
Contraindications
**CONTRAINDICATIONS** Utrogestan should not be used in individuals with any of the following conditions: - Known allergy or hypersensitivity to progesterone or to any of the excipients. - Severe hepatic dysfunction. - Undiagnosed vaginal bleeding. - Known missed abortion or ectopic pregnancy - Mammary or genital tract carcinoma. - Thromboembolic or thrombophlebitis disorders. - Cerebral haemorrhage. - Porphyria.
Indication Information
**INDICATION** Utrogestan is indicated for: Disorders related to progesterone deficit in particular menstrual irregularities due to ovulation disorders or anovulation, premenstrual disorders, breast pain or by benign breast disorders (mastopathies), bleeding due to fibroma, therapy of menopause (adjunctive use with estrogen in post-menopausal women for prevention of endometrial hyperplasia, menace of preterm delivery and can be used up to 36 week of pregnancy, threatened miscarriage or prevention of habitual miscarriage due to luteal phase deficiency up to the 12th week of pregnancy, treatment of subfertility or primary or secondary infertility related to progesterone insufficiency in particular in In Vitro Fertilization) cycles and/or oocyte donation. For all other progesterone indications, the vaginal route represents an alternative to the oral route, in case of adverse events due to Progesterone (somnolence, dizziness).